DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

AcelRx Pharmaceuticals Q4 EPS $(0.18) Beats $(0.2) Estimate, Sales $475K Miss $1.01M Estimate

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.2) by 10 percent. This is unchanged from the same period last year. The company

Benzinga · 03/16/2020 11:44

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.2) by 10 percent. This is unchanged from the same period last year. The company reported quarterly sales of $475 thousand which missed the analyst consensus estimate of $1.01 million by 52.97 percent. This is a 22.51 percent decrease over sales of $613 thousand the same period last year.